1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

1928 diagnostics AB

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2014

Location

Gothenburg Sweden

Primary Industry

Biotechnology

Established

2014

Firm Ownership

-

Investment Team Staff

Total Staff

-

Request a demo to show more

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2014
0
-
(1,342,689)
-
(1,342,689)
-
(1,335,723)
-
31 Dec 2015
0
-
(2,297,590)
-
(2,292,677)
-
(2,271,043)
-
31 Dec 2016
0
-
(5,149,833)
-
(5,144,473)
-
(5,359,976)
-
31 Dec 2017
0
-
(9,090,183)
-
(9,084,823)
-
(9,162,321)
-
31 Dec 2018
85,000
-
(8,980,268)
(10565%)
(8,972,586)
(10556%)
(9,032,610)
(10626.6%)
31 Dec 2019
159,074
87.1%
(10,352,628)
(6508.1%)
(10,019,086)
(6298.4%)
(10,384,969)
(6528.4%)
31 Dec 2020
31 Dec 2021
31 Dec 2022

Unlock the recent years of financials and more for 1928 diagnostics AB.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.